AZmed

What is AZmed?

AZmed is an AI-driven radiology platform centered on its Rayvolve® AI Suite, a computer-aided detection (CAD) software that helps radiologists and emergency physicians detect fractures on musculoskeletal X-rays and identify chest abnormalities like consolidation, pleural effusion, cardiomegaly, acute pulmonary edema, and pulmonary nodules. The tool uses advanced AI algorithms and machine learning to rapidly interpret imaging data in real-world clinical practice, enabling early pathology detection and reducing false positive rates that can fatigue the human eye.

Key features include fracture detection across 11 body regions (hand, wrist, forearm, elbow, arm, shoulder, foot, ankle, leg, knee, femur), chest X-ray analysis, automated measurement tools with 1.4° average MAE for angles and 1.3mm average MAE for lengths, and a forthcoming BoneAge module based on Greulich & Pyle methodology. The platform delivers measurable performance gains: 83% turnaround time reduction for fracture detection, 67% false negative reduction, 99.7% negative predictive value, 36% reading time reduction for chest X-rays, and 11% sensitivity improvement.

Rayvolve® is CE-marked and FDA-cleared, clinically validated by leading institutions with 30+ studies and 10+ publications, and integrates seamlessly into doctors' existing workflows without requiring habit changes. It supports computer radiography (CR), radiofluoroscopy (RF), and digital radiography (DX) for both adult and pediatric patients, though the fracture detection indication is for adults 22+ years.

The tool is designed for radiologists, emergency physicians, and healthcare facilities worldwide. AZmed serves over 2,500 healthcare centers across 25+ countries, analyzing millions of X-rays annually. The company was founded in 2018 in Paris, France, raised €15M in 2024, and employs 50+ people from 10+ nationalities.

AZmed pricing

Pricing model: Freemium

The website does not publicly disclose pricing details, free tier options, or paid plan structures. Access to Rayvolve is reserved for Healthcare Professionals legally authorized to use Class IIA medical devices in Europe or Class II devices in the USA. Healthcare facilities must contact AZmed directly at [email protected] for pricing and implementationdetails.

AZmed pros

• FDA-cleared and CE-marked for clinical use in USA and Europe
• 83% reduction in turnaround time for fracture detection
• 67% reduction in false negatives for musculoskeletal X-rays
• 99.7% negative predictive value for fracture detection
• 36% reduction in reading time for chest X-rays
• 11% improvement in sensitivity for chest pathology
• 97.9% negative predictive value for chest X-ray analysis
• Detects fractures across 11 body regions comprehensively
• Identifies 5 types of chest abnormalities including nodules
• Seamless workflow integration without changing doctor habits
• Works with CR, RF, and DX imaging modalities
• Validated by 30+ clinical studies and 10+ publications
• Used in 2,500+ healthcare facilities across 25+ countries
• Automated angle and length measurements with high precision
• Prioritizes critical cases to optimize triage workflows
• Supports both adult and pediatric patient imaging
• Reduces false positives that fatigue radiologist eyes

AZmed cons

• Fracture detection indicated for adults only (22+ years)
• No pricing transparency on public website
• BoneAge module still coming soon, not yet available
• Requires healthcare professional credentials for access
• Not intended as sole means of diagnosis, advisory only
• Class IIA medical device restrictions in Europe
• Class II medical device restrictions in USA
• Limited to X-ray imaging, no CT or MRI support
• Non-certified countries only have trial access

Use cases

• Upscale Images
• Lead Generation